Prescribing of FDA-approved and compounded hormone therapy differs by specialty

OBJECTIVE: To determine the prescribing patterns of general practitioners (GPs), obstetrician/gynecologists (OB/GYNs), and wellness physicians (WPs) of menopausal hormone therapy (HT) for both compounded (CHT) and Food and Drug Administration (FDA)-approved products, using a survey of US physicians....

Descripción completa

Detalles Bibliográficos
Autores principales: Constantine, Ginger D., Archer, David F., Graham, Shelli, Bernick, Brian A., Mirkin, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott-Raven Publishers 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028143/
https://www.ncbi.nlm.nih.gov/pubmed/27648594
http://dx.doi.org/10.1097/GME.0000000000000683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028143/
https://www.ncbi.nlm.nih.gov/pubmed/27648594
http://dx.doi.org/10.1097/GME.0000000000000683

Ejemplares similares